Bill analyzes regional and state trends in the U.S. healthcare industry and is a national expert on health exchanges and Medicare. He authors National MCO Analyzers and Market Overviews in multiple regions as well as U.S. Access and Reimbursement reports focusing on autoimmune drugs and opioids.
Latest news
Clarivate RiskMark Wins 2025 LegalTech Breakthrough Award For “LegalTech Predictive AI Solution of the Year”
Annual awards program recognizes companies and products driving innovation in the global legal technology industry AI-powered RiskMark delivers near-instant, data-backed insights London, U.K. November 13, 2025. Clarivate Plc (NYSE:CLVT), a…
Clarivate to Present at the RBC Capital Markets Global Technology, Internet, Media and Telecommunications Conference on November 19
London, UK – November 13, 2025, Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, announced today that Matt Shem Tov, Chief Executive Officer, and Jonathan Collins, Executive…